Tonix Pharmaceuticals (TNXP) Misses Q1 EPS by 17c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q1 EPS of ($0.71), $0.17 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c